The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use
Abstract
Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) develops at a low level following drug treatment, and person-to-person transmission of resistant virus has not been recognized to date. The Neuraminidase Inhibitor Susceptibility Network (NISN) was established to follow susceptibility of isolates and occurrence of NAI resistance at a population level in various parts of the world. Isolates from the WHO influenza collaborating centers were screened for susceptibilities to oseltamivir and zanamivir by a chemiluminescent enzyme inhibition assay, and those considered potentially resistant were analyzed by sequence analysis of the neuraminidase genes. During the first 3 years of NAI use (1999 to 2002), 2,287 isolates were tested. Among them, eight (0.33%) viruses had a >10-fold decrease in susceptibility to oseltamivir, one (0.22%) in 1999 to 2000, three (0.36%) in 2000 to 2001, and four (0.41%) in 2001 to 2002. Six had unique changes in the neuraminidase gene compared to neuraminidases of the same subtype in the influenza sequence database. Although only one of the mutations had previously been recognized in persons receiving NAIs, none were from patients who were known to have received the drugs. During the 3 years preceding NAI use, no resistant variants were detected among 1,054 viruses. Drug use was relatively stable during the period, except for an approximate 10-fold increase in oseltamivir use in Japan during the third year. The frequency of variants with decreased sensitivity to the NAIs did not increase significantly during this period, but continued surveillance is required, especially in regions with higher NAI use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children
Izurieta, H. S., Thompson, W. W., Kramarz, P., Shay, D. K., Davis, R. L., DeStefano, F., Black, S., Shinefield, H., & Fukuda, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420402 · Cited by 1,012
Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection
de Jong, M. D., Thanh, T. T., Khanh, T. H., Hien, V. M., Smith, G. J. D., Chau, N. V., Cam, B. V., Qui, P. T., Ha, D. Q., Guan, Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa054512 · Cited by 901
Avian Influenza A (H5N1) in 10 Patients in Vietnam
Hien, T. T., Liem, N. T., Dung, N. T., San, L. T., Mai, P. P., Chau, N. V. V., Suu, P. T., Dong, V. C., Mai, L. T. Q., Thi, N. T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040419 · Cited by 839
Resistant influenza A viruses in children treated with oseltamivir: descriptive study
Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 786
Self-citationInfluenza virus neuraminidase inhibitors
Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11433-8 · Cited by 730
Self-citationOral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Self-citationEvidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
Gubareva, L. V., Matrosovich, M. N., Brenner, M. K., Bethell, R. C., & Webster, R. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/314440 · Cited by 432
Self-citationOseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
Ward, P., Small, I., Smith, J., Suter, P., & Dutkowski, R. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki018 · Cited by 428
Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
Hayden, F. G., Belshe, R. B., Clover, R. D., Hay, A. J., Oakes, M. G., & Soo, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212502 · Cited by 416
Self-citationIves, J. A. L., Carr, J. A., Mendel, D. B., Tai, C. Y., Lambkin, R., Kelly, L., Oxford, J. S., Hayden, F. G., & Roberts, N. A. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00053-0 · Cited by 379
Self-citationResistance of influenza viruses to neuraminidase inhibitors — a review
MCKIMMBRESCHKIN, J. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00103-0 · Cited by 320
Self-citationInfluenza Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in Ferrets
Herlocher, M. L., Truscon, R., Elias, S., Yen, H., Roberts, N. A., Ohmit, S. E., & Monto, A. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/424572 · Cited by 292
Self-citationMcKimm-Breschkin, J., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F., & Zambon, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2264-2272.2003 · Cited by 291
Self-citationInfluenza-Related Hospitalizations among Children in Hong Kong
Chiu, S. S., Lau, Y. L., Chan, K. H., Wong, W. H. S., & Peiris, J. S. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020546 · Cited by 286
Govorkova, E. A., Leneva, I. A., Goloubeva, O. G., Bush, K., & Webster, R. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2723-2732.2001 · Cited by 240
Self-citationWetherall, N. T., Trivedi, T., Zeller, J., Hodges-Savola, C., McKimm-Breschkin, J. L., Zambon, M., & Hayden, F. G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.742-750.2003 · Cited by 207
Self-citationVarghese, J. N., Smith, P. W., Sollis, S. L., Blick, T. J., Sahasrabudhe, A., McKimm-Breschkin, J. L., & Colman, P. M. (1998) · Structure · doi:10.1016/s0969-2126(98)00075-6 · Cited by 201
Self-citationCarr, J., Ives, J., Kelly, L., Lambkin, R., Oxford, J., Mendel, D., Tai, L., & Roberts, N. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00215-7 · Cited by 175
Estimates of the US health impact of influenza.
Sullivan, K. M., Monto, A. S., & Longini, I. M. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.12.1712 · Cited by 166
Self-citationInfluenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets
Herlocher, M. L., Carr, J., Ives, J., Elias, S., Truscon, R., Roberts, N. A., & Monto, A. S. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00214-5 · Cited by 158
Self-citationMast, E. E., Harmon, M. W., Gravenstein, S., Wu, S. P., Arden, N. H., Circo, R., Tyszka, G., Kendal, A. P., & Davis, J. P. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116184 · Cited by 153
Position statement: global neuraminidase inhibitor susceptibility network
Zambon, M. C. F. A., & Hayden, F. G. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00124-3 · Cited by 153
Self-citationThe role of antivirals in the control of influenza
Monto, A. S. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00075-6 · Cited by 121
Self-citationAn Introduction to Contemporary Statistics.
Stephenson, W. R., Kempthorne, O., & Koopmans, L. H. (1984) · Journal of the American Statistical Association · doi:10.2307/2288366 · Cited by 97
Macdonald, S. J. F., Cameron, R., Demaine, D. A., Fenton, R. J., Foster, G., Gower, D., Hamblin, J., Hamilton, S., Hart, G. J., Hill, A. P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040891b · Cited by 93
Self-citationManagement of Influenza: Use of New Antivirals and Resistance in Perspective
Jackson, H. C., Roberts, N. A., Wang, Z. M., & Belshe, R. B. (2000) · Clinical Drug Investigation · doi:10.2165/00044011-200020060-00007 · Cited by 68
Hurt, A. C., McKimm‐Breschkin, J. L., McDonald, M., Barr, I., Komadina, N., & Hampson, A. W. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.035 · Cited by 25
Self-citation
Cited by
The Pathology of Influenza Virus Infections
Taubenberger, J. K., & Morens, D. M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154316 · Cited by 1,111
Harper, S. A., Bradley, J. S., Englund, J. A., File, T. M., Gravenstein, S., Hayden, F. G., McGeer, A. J., Neuzil, K. M., Pavia, A. T., Tapper, M. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598513 · Cited by 647
Self-citationInfluenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
Gamblin, S. J., & Skehel, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.129809 · Cited by 638
Deyde, V. M., Xu, X., Bright, R. A., Shaw, M., Smith, C. B., Zhang, Y., Shu, Y., Gubareva, L. V., Cox, N. J., & Klimov, A. I. (2007) · The Journal of Infectious Diseases · doi:10.1086/518936 · Cited by 543
Self-citationInfections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Dharan, N. J. (2009) · JAMA · doi:10.1001/jama.2009.294 · Cited by 527
Metadata
- Authors
- Monto, A. S., McKimm-Breschkin, J. L., Macken, C., Hampson, A. W., Hay, A., Klimov, A., Tashiro, M., Webster, R. G., Aymard, M., Hayden, F. G., & Zambon, M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-07
- Volume
- 50
- Issue
- 7
- Pages
- 2395-2402
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2111155300
- Cited by
- 364
- References
- 28
- FWCI
- 24.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.